Mo Jain - novel technologies for biomarker discovery

<p>Mo Jain, Founder and CEO of Sapient, discusses the importance of small molecule biomarkers and his approach to biomarker discovery research. </p> <p>The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of biotechnology companies, with a focus on genomics.</p> <p>https://www.bioinformaticscro.com/</p>